Mostrar registro simples

dc.contributor.authorSchwarz, Karinept_BR
dc.contributor.authorVillas-Bôas, Anna Paula de Sápt_BR
dc.contributor.authorCielo, Carla Aparecidapt_BR
dc.contributor.authorSilva, Dhiordan Cardoso dapt_BR
dc.contributor.authorSilva, Eliane Dias dapt_BR
dc.contributor.authorFighera, Tayane Munizpt_BR
dc.contributor.authorCosta, Angelo Brandellipt_BR
dc.contributor.authorLobato, Maria Inês Rodriguespt_BR
dc.contributor.authorSpritzer, Poli Marapt_BR
dc.date.accessioned2025-02-26T06:49:38Zpt_BR
dc.date.issued2024pt_BR
dc.identifier.issn2296-2565pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/287665pt_BR
dc.description.abstractObjectives: The aim of this study was to adapt and apply the Portuguese version of the Transgender Man Voice Questionnaire in a sample of Brazilian transgender men and to investigate the relationship between voice satisfaction and hormone therapy duration. In addition, we suggest reducing and reformulating the questionnaire for screening. Methods: We conducted a cross-sectional study of 31 transgender men aged 18–50 years undergoing hormone therapy who answered a questionnaire adapted from the Transgender Woman Voice Questionnaire, validated in Portuguese. Sociodemographic and clinical data were collected from the individuals’ electronic medical records: age, smoking status, and type and duration of hormone therapy. The questionnaire, consisting of 30 questions rated on a Likert scale, was answered individually during a psychotherapy session. In each question, the gender-specific words were modified. Furthermore, we added a question: 31 (After GAHT, my voice became completely male), with the response options yes or no. In questions 32 and 33, asking participants to provide an overall rating of their voice. Total score ranged from 0 to 120, with higher scores indicating greater dissatisfaction with voice. Results: Mean patient age was 30.13 ± 7.6 years, and 19.4% were smokers. The mean duration of hormone therapy was 29.7 ± 24.9 months, and 95% received intramuscular testosterone cypionate, maintaining serum testosterone levels within the male reference range. The questionnaire mean total score was 51 ± 17.72. There was a significant negative correlation between the questionnaire total score and duration of hormone therapy (r = −0.484, p = 0.006). The questionnaire had a high level of internal consistency/reliability, with a Cronbach’s alpha coefficient of 0.95 for all items and a split-half Spearman-Brown coefficient of 0.96. For the elaboration of a screening tool, it is suggested to remove questions 8, 10, 12, 13, 14, 17, 19, 23, 27, and 29 and modify question 1. Conclusion: Longer hormone therapy favors voice deepening and satisfaction with voice. The psychometric properties of the Transgender Man Voice Questionnaire are reliable, supporting its use as a screening tool in clinical practice and as an adjunct to the planning of vocal and communication support for transgender individuals.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofFrontiers in public health. Lausanne. Vol. 12 (Dec. 2024), 1480423, 7 p.pt_BR
dc.rightsOpen Accessen
dc.subjectPessoas transgêneropt_BR
dc.subjectVoiceen
dc.subjectQualidade da vozpt_BR
dc.subjectVoice satisfactionen
dc.subjectVozpt_BR
dc.subjectGender identityen
dc.subjectTransgenderen
dc.subjectInquéritos e questionáriospt_BR
dc.subjectHormone therapyen
dc.titleApplication of the transgender male voice questionnaire in a Brazilian population samplept_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001242045pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples